Latest Documents


  • 20-February-2017

    English

    Measuring health coverage

    OECD governments have to decide whether they want to cover more services at a limited reimbursement rate, or whether they want to extend more the financial protection for a limited number of services.

    Related Documents
  • 15-February-2017

    English

    Graph of the Month

    The OECD Health Division is releasing a new series to highlight its work on health policies and data. A new graph will be available each month.

    Related Documents
  • 16-January-2017

    English

    Policy Forum on the Future of Health

    This High-Level Forum will be held at the OECD Conference Centre in Paris on 16 January 2017. Issues include: Harnessing digital technology and data to create proactive, people-centred systems; Overcoming technical, institutional and cultural challenges; Caring for people with complex needs; The importance of measuring what matters to people and to patients, and The role of international and cross-sector collaboration.

    Related Documents
  • 16-January-2017

    English, PDF, 1,422kb

    Patient-Reported Indicators Survey: Booklet

    Patient-Reported Indicators Survey: Explanatory Booklet

    Related Documents
  • 16-January-2017

    English, PDF, 1,816kb

    Recommendations to OECD Ministers of Health from the High-Level Reflection Group on the Future of Health Statistics

    Recommendations to OECD Ministers of Health from the High-Level Reflection Group on the Future of Health Statistics: Strengthening the international comparison of health system performance through patient-reported indicators.

    Related Documents
  • 16-January-2017

    English

    New Health Technologies - Managing Access, Value and Sustainability

    This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.

  • 10-January-2017

    English

    Reviews of National Health Care Quality

    OECD Health Care Quality Reviews seek to examine what works and what does not work in different countries – both to benchmark the efforts of countries and to provide advice on reforms to improve their health system.

  • 10-January-2017

    English

    Tackling Wasteful Spending on Health

    Following a brief pause after the economic crisis, health expenditure is rising again in most OECD countries. Yet, a considerable part of this health expenditure makes little or no contribution to improving people's health. In some cases, it even results in worse health outcomes. Countries could potentially spend significantly less on health care with no impact on health system performance, or on health outcomes. This report systematically reviews strategies put in place by countries to limit ineffective spending and waste. On the clinical front, preventable errors and low-value care are discussed. The operational waste discussion reviews strategies to obtain lower prices for medical goods and to better target the use of expensive inputs. Finally, the report reviews countries experiences in containing administrative costs and integrity violations in health.

  • 21-December-2016

    English

    Pharmaceutical Pricing Policy project

    The policy study published by the OECD is based on six case studies, an extensive review of the literature, and analysis of relevant data. The report provides context for the analysis of pharmaceutical pricing policies in OECD countries, describes pricing policies employed by the OECD zone and assesses their impact.

  • 21-December-2016

    English

    Value in Pharmaceutical Pricing

    The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>